Ivonescimab (SMT112, AK112), a first-in-class, humanized, tetravalent PD-1/VEGF bispecific monoclonal antibody, being internally developed by Akeso Biopharma (a China-based commercial-stage biopharmaceutical company), has shown exceptional results in
Section 26 of the Indian Patents Act provides inventors with a mechanism to prevent their work from being unfairly patented by someone else, and the
First, let’s understand what patents are with a simple example. Amazon had a one-click patent that allowed customers to place orders in one click by
Is Merck ready to face the looming patent cliff? Impact of Inflation Reduction Act (IRA) on Keytruda Inflation Reduction Act (IRA) was passed in 2022
The US FDA approval of Fresenius Kabi’s Tyenne®, the first Tocilizumab biosimilar with both intravenous and subcutaneous formulations, is a breakthrough in bringing high-quality, affordable,
Patent linkage system serves as a crucial tool in the pharmaceutical industry, strategically aligning the approval process of generic drugs with the patent status of
